Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By boosting these receptors, https://barbarakrnu962276.bloggin-ads.com/59331925/tirzepatide-a-promising-new-treatment-for-obesity